NEW YORK (GenomeWeb) – PerkinElmer said today that it has priced an offering of €300 million ($368 million) aggregate principal amount of 0.6 percent senior notes due 2021.

The issuance of the notes is expected to close on April 11, subject to customary closing conditions. The notes will pay interest on an annual basis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.